Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Add GEN to your Inbox FREE!

Subscribe today to our complimentary e-Newsletters and stay abreast of the latest biotech news and trends.


DISCOVERING DRUGS AND BIOFUELS IN TROPICAL SEAS

11/13/2008

- Margo Haygood, Ph.D., Professor of Marine and Biomolecular Systems, Environmental and Biomolecular Systems Division, Department of Science and Engineering, Oregon Health & Science University

The NIH recently awarded $4 million to a group of Philippine and American scientists led by Oregon Health & Science University to aid in the discovery of new molecules and biofuels technology from marine mollusks for development in the Philippines. The project will concentrate its research in the Philippine archipelago whose waters are inhabited by an estimated 10,000 marine mollusk species, or about one-fifth of all the known species, and are regarded by marine biologists as the world's epicenter of marine biodiversity. Mollusks are among the most diverse of marine animals and include shelled creatures like snails, clams, and slugs.


During this week's podcast, Dr. Haygood, lead investigator of the study, explains why marine mollusks and associated microbes offer such promise for the discovery of new central nervous system, anticancer, and antimicrobial drugs as well as enzymes for cellulosic biofuels production. She provides additional key details about the project and discusses the roles of the The National Science Foundation and the U.S. Department of Energy, which are also sponsors of the grant.
Margo G. Haygood, PH.D. is a Professor in the Environmental and Biomolecular Systems Department of OGI School of Science and Engineering at Oregon Health and Science University.

Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

FDA on Biosimilars

How satisfied are you with progress toward bringing biosimilars to the U.S. market?

Suggest a Poll